Advertisement

Index by author

October 01, 1999; Volume 27,Issue 10

  1. Abe, Tomio

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  2. Aldridge, Susanna L. K.

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  3. Andersson, Tommy B.

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  4. Appleton, Scott D.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  5. Backman, Assar

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  6. Balis, Frank M.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

  7. Berg, Mikael

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  8. Bergh, Jonas

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  9. Beschke, K.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

  10. Bolten, Suzanne

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
« Previous (Pages : 1 2 3 4 5 6 ... 11) Next »
Back to top

In this issue

Advertisement